Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007
- PMID: 17625496
Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007
Abstract
Progress toward global polio eradication continued during 2006 and the first 5 months of 2007, although the number of countries where wild poliovirus (WPV) transmission has never been interrupted remained at four (Afghanistan, India, Nigeria, and Pakistan). Continuing challenges included intense WPV circulation in northern India during 2006, low vaccination coverage with oral polio vaccine (OPV) during supplemental immunization activities (SIAs) in Nigeria, and security problems preventing access to children during SIAs along the Afghanistan-Pakistan border. Programmatic strategies to address these challenges consisted of large-scale use of type 1 monovalent oral polio vaccine (mOPV1), targeted programs (e.g., cross-border synchronization of polio campaigns) to reach more children through SIAs, and introduction of new laboratory procedures to confirm cases more rapidly. This report summarizes these strategies and overall progress toward global polio eradication.
Similar articles
-
Progress toward interruption of wild poliovirus transmission--worldwide, January 2007-April 2008.MMWR Morb Mortal Wkly Rep. 2008 May 9;57(18):489-94. MMWR Morb Mortal Wkly Rep. 2008. PMID: 18463607
-
Progress toward poliomyelitis eradication--Nigeria, 2005-2006.MMWR Morb Mortal Wkly Rep. 2007 Mar 30;56(12):278-81. MMWR Morb Mortal Wkly Rep. 2007. PMID: 17392680
-
Progress toward poliomyelitis eradication--Pakistan and Afghanistan, 2007.MMWR Morb Mortal Wkly Rep. 2008 Mar 28;57(12):315-9. MMWR Morb Mortal Wkly Rep. 2008. PMID: 18368007
-
The global polio eradication initiative: lessons learned and prospects for success.Vaccine. 2011 Dec 30;29 Suppl 4:D80-5. doi: 10.1016/j.vaccine.2011.10.005. Vaccine. 2011. PMID: 22486981 Review.
-
Epidemiology of poliomyelitis--options and update.Vaccine. 2008 Oct 23;26(45):5767-73. doi: 10.1016/j.vaccine.2008.07.101. Epub 2008 Aug 26. Vaccine. 2008. PMID: 18755232 Review.
Cited by
-
Genetic relationships and epidemiological links between wild type 1 poliovirus isolates in Pakistan and Afghanistan.Virol J. 2012 Feb 22;9:51. doi: 10.1186/1743-422X-9-51. Virol J. 2012. PMID: 22353446 Free PMC article.
-
Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar.PLoS Pathog. 2007 Dec;3(12):e191. doi: 10.1371/journal.ppat.0030191. PLoS Pathog. 2007. PMID: 18085822 Free PMC article.
-
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.J Virol. 2009 Sep;83(17):8693-704. doi: 10.1128/JVI.02388-08. Epub 2009 Jun 10. J Virol. 2009. PMID: 19515771 Free PMC article.
-
Polio-philanthropy in Africa: A narrative review.Health Sci Rep. 2023 Jun 14;6(6):e1339. doi: 10.1002/hsr2.1339. eCollection 2023 Jun. Health Sci Rep. 2023. PMID: 37324246 Free PMC article.
-
Distribution pattern of poliovirus potentially infectious materials in the phase 1b medical laboratories containment in conformity with the global action plan III.BMC Public Health. 2018 Dec 13;18(Suppl 4):1319. doi: 10.1186/s12889-018-6183-1. BMC Public Health. 2018. PMID: 30541511 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical